StonvexLoading…
StonvexCore line items from RC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $81.73M | $569.17M | $445.19M | $307.70M |
Operating Income | $-216.76M | $-302.56M | $-38.37M | $-11.49M |
Net Income | $-200.09M | $-221.06M | $11.55M | $28.29M |
EPS (Diluted) | $-1.25 | $-1.44 | $-0.01 | $0.12 |
Total Assets | $6.31B | $7.77B | $8.33B | $9.31B |
Total Liabilities | $4.87B | $6.12B | $6.45B | $7.37B |
Cash & Equivalents | $200.43M | $207.84M | $147.50M | $162.94M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 165.26M | 163.01M | 161.83M | 164.33M |